It’s true, it’s been reported in the news.
According to the Russian Satellite News Agency on the 26th, the WHO Strategic Advisory Group of Experts on Immunization met on January 21 to evaluate the preliminary data from the Phase III clinical trial of Moderna’s new coronavirus vaccine, mRNA-1273.
Considering the possibility of allergic reactions after vaccination with this vaccine, WHO experts recommend that vaccination be provided only under conditions that can prevent anaphylactic shock in recipients.
The expert group does not recommend that pregnant women be vaccinated with mRNA-1273 unless they belong to high-risk groups (such as medical workers). The expert group pointed out that given the current shortage of vaccines and the lack of evidence that vaccines can reduce the risk of COVID-19 transmission, it is not recommended to prioritize vaccination for travelers.
According to an earlier report by Xinhua News Agency, a report released by the U.S. Centers for Disease Control and Prevention on the 22nd showed that as of January 10, 4,041,396 people in the United States had received the first dose of U.S. Modex. The COVID-19 vaccine developed by Nanotech has reported 1,266 adverse events, including 10 allergic reactions.
The United States reported:
According to the U.S. Centers for Disease Control and Prevention, allergic reactions are serious, life-threatening adverse reactions that usually occur within minutes to hours after vaccination.
These 10 cases were confirmed to be allergic reactions, of which 9 occurred within 15 minutes after vaccination and 1 occurred 45 minutes after vaccination; 108 cases may be serious adverse reactions including allergic reactions. The incident requires further investigation.
The U.S. Food and Drug Administration approved the emergency use authorization application for Moderna’s COVID-19 vaccine on December 18, 2020. This is the second COVID-19 vaccine approved for emergency use in the United States after the COVID-19 vaccine jointly developed by Pfizer Pharmaceuticals Co., Ltd. of the United States and the German Biotech Company. It is allowed to be used for people aged 18 and above, and requires two doses. 1 month apart.
Reference for the above content:
Baidu Encyclopedia - Moderna COVID-19 Vaccine